Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

about

Refining Ethical Guidelines for Early Clinical Trials of Pluripotent Stem-Cell-Derived Therapeutics for Parkinson's Disease

P2860

Q58172885-AEA71CCF-FC0B-4715-B9E7-8AE3E007F0C6

P2860

Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

Item

http://www.wikidata.org/entity/Q42545361

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

@en

Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

@nl

type

Item

label

Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

@en

Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

@nl

prefLabel

Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

@en

Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

@nl

P1476

Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

@en

P2093

Catherine Priest

http://www.w3.org/2001/XMLSchema#string

Ellen G Feigal

http://www.w3.org/2001/XMLSchema#string

Geoffrey P Lomax

http://www.w3.org/2001/XMLSchema#string

Rosa Canet-Aviles

http://www.w3.org/2001/XMLSchema#string

P2860

Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease

Parkinson's Disease: Genetics and Pathogenesis

Intraneuronal dopamine-quinone synthesis: A review

Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease

LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress

Progressive degeneration of human neural stem cells caused by pathogenic LRRK2

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.

Genome-wide association study reveals genetic risk underlying Parkinson's disease

Using stem cells and iPS cells to discover new treatments for Parkinson's disease

Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders

P304

979-991

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5966/SCTM.2014-0146

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25150264

http://www.w3.org/2001/XMLSchema#string

P932

4149307

http://www.w3.org/2001/XMLSchema#string

Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

about

P2860

P2860

Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932